Outcomes and tolerability of bendamustine dose reductions when used in combination with anti-CD20 antibody as initial therapy in elderly patients with indolent lymphoproliferative disorders.

Authors

Jennifer Yao, Anna Johnston, Jared Fairbank, Melissa Armstrong, Kate Manos, David Mathers, Mark Hertzberg, Amanda Tey, Ashley Whitechurch, Miles Ma, Anthony Jeffrey, Catelyn Cashion, Nicholas Parkes, Yao Ly, Eliza A Hawkes, Adrian Yeung, Andrew Grigg

Published in

Leukemia & lymphoma. Pages 1-4. Oct 20, 2026. Epub Oct 20, 2026.

PMID:
42900620
Bibliographic data and abstract were imported from PubMed on 21 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.